2021 Keynote Information
Celebrating its 12th successful year, SCOPE Summit 2021 takes place March 2-4, 2021 as a fully virtual event. During these difficult times of a global pandemic, the work this clinical research community does is more important than ever and requires collaboration
and innovation. Over the course of three stimulating days of in-depth discussions in 23 different conferences, 5 plenary keynote sessions, the 5th annual Participant Engagement Awards, the new China Clinical Development Partnering event and the ever-popular
interactive breakout discussions, the programming focuses on advances and innovative solutions in all aspects of clinical trial innovation, planning, management and operations, including: De-Centralized Trials, Site Selection and Management, Patient
Engagement, Recruitment and Retention, Protocol Optimization, Feasibility, Telemedicine, Data Strategy and Analytics, Sensors and Wearables, Project Management, Outsourcing, Forecasting, Budgeting and Contracting, Resource Management, Quality (QbD)
in Trial Conduct, Risk-Based Monitoring, Artificial Intelligence, Post-Marketing Studies, Observational Research, Accessing and Generating RWD, Clinical Biomarker Strategy, Clinical Supply Chain, Precision Medicine, Clinical Biomarkers and Biospecimens,
and Central Lab Solutions, and expanded coverage on Medical Device Clinical Trial Operations and Regulations and Clinical Supply. SCOPE attracted more than 2,200 leaders in clinical operations and research in 2020, and we look forward to you and your
team joining us in the first ever virtual SCOPE!
View All 22 Conference Programs | Breakouts | Participant Engagement Award
TUESDAY, MARCH 2, 2021
FIRESIDE CHAT: Acceleration of Drug Dev Due to the Pandemic -- Lessons Learned, What Were those Accelerants, Strategic Implications
Moderator: Deborah Borfitz, Senior Science Writer,
Clinical Research News & Bio-IT World
Ken Getz, MBA, Founder, CISCRP; Deputy Director, Center
for the Study of Drug Development, Tufts University School of Medicine
Leonard Sacks, MD, Acting Deputy Director, Office of Medical Policy, CDER, FDA
CASE STUDY: Working Under Pressure COVID-19 Edition: Pfizer’s Vaccine Trial Decision-Making Strategies and Technology-Boosted Operations
Demetris Zambas, Vice President and Global Head,
Data Monitoring and Management, Pfizer
Brett Wilson, Senior Director, Cardiovascular
TA Lead Data Monitoring and Management, Pfizer
Ralph Russo, Senior Director and Global Head,
Clinical Database Management, Pfizer
SCOPE's 2021 Participant Engagement Awards
CREATIVITY AND ENGAGEMENT IN RECRUITMENT AND RETENTION COMMUNICATIONS
https://www.scopesummit.com/participant-engagement-award
CHAIRPERSON: David Sall, President & CEO, Patient
Enrollment Advisors; Co-Creator of the SCOPE Participant Engagement Award
Kelly McKee, Senior Director, Patient Recruitment and
Registries, Medidata; Co-Creator of the SCOPE Participant Engagement Award
Phyllis Kaplan, Trial Volunteer and Patient Advocate;
Senior Project Manager, Health Communication Services, Center for Information & Study on Clinical Research Participation (CISCRP)
Cassandra Smith, Associate
Director Investigator & Patient Engagement, Janssen R&D LLC
Irfan Khan, MD, CEO, Circuit Clinical - TrialScout
Micah Lieberman, Executive Director, Conferences,
Cambridge Healthtech Institute (CHI)
wednesday, MARCH 3, 2021
Enhancing Patient and Site Centricity and Driving Clinical Research Innovation through Technology
Darren Weston, Vice President, Integrated Data Analytics
& Reporting (IDAR), Janssen
Virtual Investigator Meetings During COVID-19 & Beyond
Marina Ziehn, PhD, Global Medical Affairs Director, Novartis Pharmaceuticals
Markus Krüer, MD, Head of Clinical Project Management, Merz Therapeutics
Steven Sulkin, Founder & CEO, SimuLyve International, Inc
Nico Wegener, MD, Senior Clinical Project Manager, Merz Pharmaceuticals, GmbH
Richard Scher, MD, FACS, Medical Director, Clinical Science, Board Certified Otolaryngologist-Head & Neck Surgeon, Merz Aesthetics, North America
THURSDAY, MARCH 4, 2021
Social Determinants of Health (SDoH) and Its Relevance to Clinical Trials
Conrod Kelly, Executive Director, Marketing and Brand
Strategy, Organizational Transformation and Growth; Executive Director, Policy, Government Relations, Merck
INTERACTIVE PANEL: Moving Toward Platform Thinking: Creating a More Seamless Front-End and Back-End to Future-Proof and Advance Digital Transformation in Pharma
Moderator: Adama Ibrahim, EMBA, Director, Digital
Solutions, Novartis
Hassan Kadhim, MBA, Director, Head of Clinical Trial
Business Capabilities, Global Development Operations, Bristol Myers Squibb
Craig Lipset, MBA, Former Head, Clinical Innovation,
Pfizer; Venture Partner, Boston Millennia Partners (BMP) & FundRx; Advisor, People-Centered Research Foundation (PCRF)
Mohammed Ali, Global Head, Digital Development, Global
Clinical Operations, Boehringer Ingelheim
Disa Lee Choun, Head, GCSO Innovation,
UCB Pharma